Comparison of diffusion-weighted MRI acquisition techniques for normal pancreas at 3.0 Tesla

Precision of liver and pancreas apparent diffusion coefficients using motion-compensated gradient waveforms in DWI

BACKGROUND

Diffusion weighted imaging (DWI) with optimized motion-compensated gradient waveforms reduces signal dropouts in the liver and pancreas caused by cardiovascular-associated motion, however its precision is unknown. We hypothesized that DWI with motion-compensated DW gradient waveforms would improve apparent diffusion coefficient (ADC)-repeatability and inter-reader reproducibility compared to conventional DWI in these organs.

METHODS

In this IRB-approved, prospective, single center study, subjects recruited between October 2019 and March 2020 were scanned twice on a 3 T scanner, with repositioning between test and retest. Each scan included two respiratory-triggered DWI series with comparable acquisition time: 1) conventional (monopolar) 2) motion- compensated diffusion gradients. Three readers measured ADC values. One-way ANOVA, Bland-Altman analysis were used for statistical analysis.

RESULTS

Eight healthy participants (4 male/4 female), with a mean age of 29 ± 4 years, underwent the liver and pancreas MRI protocol. Four patients with liver metastases (2 male/2 female) with a mean age of 58 ± 5 years underwent the liver MRI protocol. In healthy participants, motion-compensated DWI outperformed conventional DWI with mean repeatability coefficient of 0.14 × 10-3 (CI:0.12-0.17) vs. 0.31 × 10-3 (CI:0.27-0.37) mm2/s for liver, and 0.11 × 10-3 (CI:0.08-0.15) vs. 0.34 × 10-3 (CI:0.27-0.49) mm2/s for pancreas; and with mean reproducibility coefficient of 0.20 × 10-3 (CI:0.18-0.23) vs. 0.51 × 10-3 (CI:0.46-0.58) mm2/s for liver, and 0.16 × 10-3 (CI:0.13-0.20) vs. 0.42 × 10-3 (CI:0.34-0.52) mm2/s for pancreas. In patients, improved repeatability was observed for motion-compensated DWI in comparison to conventional with repeatability coefficient of 0.51 × 10- 3 mm2/s (CI:0.35-0.89) vs. 0.70 × 10-3 mm2/s (CI:0.49-1.20).

CONCLUSION

Motion-compensated DWI enhances the precision of ADC measurements in the liver and pancreas compared to conventional DWI.

Effects of different breathing techniques on the IVIM-derived quantitative parameters of the normal pancreas

PURPOSE

To prospectively compare the differences in intravoxel incoherent motion (IVIM)-derived quantitative parameters in different anatomic locations of the normal pancreas with different breathing techniques in a healthy population.

METHOD

Twenty-six volunteers successfully underwent pancreas axial IVIM imaging with a 3.0-T MR system using 11 b-values (from 0 to 1000 sec/mm²) with three different breathing techniques: free breath (FB), liver dome scout (LDS), and phase scout (PS). The IVIM-derived quantitative parameters in three anatomic locations (head, body, and tail of the pancreas) were calculated. The intra-, inter-, and short-term consistency of IVIM-derived quantitative parameters were assessed by comparing 95% confidence interval (CI) of limits of agreement (LOA) of difference between measurements and clinical maximum allowed difference using the Bland-Altman method. The Kruskal-Wallis test was used to compare pancreatic IVIM-derived parameters.

RESULTS

In Bland-Altman graph, the maximum values of the 95% CIs of LOAs of D_slow, D_fast, and f were (0.123 ± 0.022) × 10^-3 mm²/sec, (22.093 ± 4.997) × 10^-3 mm²/sec, and (3.942 ± 0.621)%, and the consistency of D_slow and f was good and that of D_fast was poor overall. The D_slow, D_fast, and f values of normal pancreas were (1.056 ± 0.121) × 10^-3 mm²/sec, (55.755 ± 13.011) × 10^-3 mm²/sec, and (26.036 ± 2.361)%, respectively, and there aren't any breathing technique (P > 0.05) or location (P > 0.05) dependent differences.

CONCLUSIONS

Our study shows that IVIM-derived quantitative parameters of the pancreas may not be affected by breathing techniques and anatomic locations. The f and D_slow values have good repeated measurement consistency under different breathing techniques.

Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes

Aims

This study harnessed the electronic medical record to assess pancreas volume in patients with type 1 diabetes (T1D) and matched controls to determine whether pancreas volume is altered in T1D and identify covariates that influence pancreas volume.

Methods

This study included 25 patients with T1D and 25 age-, sex-, and weight-matched controls from the Vanderbilt University Medical Center enterprise data warehouse. Measurements of pancreas volume were made from medical imaging studies using magnetic resonance imaging (MRI) or computed tomography (CT).

Results

Patients with T1D had a pancreas volume 47% smaller than matched controls (41.16 ml vs. 77.77 ml, P < 0.0001) as well as pancreas volume normalized by subject body weight, body mass index, or body surface area (all P < 0.0001). Pancreatic volume was smaller with a longer duration of T1D across the patient population (N = 25, P = 0.04). Additionally, four individual patients receiving multiple imaging scans displayed progressive declines in pancreas volume over time (~ 6% of volume/year), whereas five controls scanned a year apart did not exhibit a decline in pancreas size (P = 0.03). The pancreas was uniformly smaller on the right and left side of the abdomen.

Conclusions

Pancreas volume declines with disease duration in patients with T1D, suggesting a protracted pathological process that may include the exocrine pancreas.